Clinical trialNCT04009109Active, not recruitingPhase 2Interventional

Study of Lenalidomide/Ixazomib/Dexamethasone/Daratumumab in Transplant-Ineligible Patients With Newly Diagnosed MM

SponsorAlliance Foundation Trials, LLC.Enrollment79Myeloma, Multiple

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Andrew Yee, MD
Massachusetts General Hospital
Study ChairKOL profile →
clinicaltrials.gov ↗
Evanthia Galanis, MD
Alliance Foundation Trials, LLC.
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Northern Light Eastern Maine Medical Center
Bangor, Maine, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
University of Nebraska Medical Center
Omaha, Nebraska, United States
Suny Upstate Medical Center
Syracuse, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Gibbs Cancer Center & Research Institute/spartanburg Regional Healthcare
Spartanburg, South Carolina, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 21 Oct 2020
Primary completion: 31 Dec 2026
Completion: 30 Jun 2027
Last update posted: 18 Dec 2025
Registered enrollment: 79
Registry id: NCT04009109

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.